-- 根據週二提交給香港交易所的文件顯示，中國生物製藥有限公司（港交所代碼：1177）已任命康曉燕為首席醫療官。 中國生物製藥表示，康曉燕在臨床實務和藥物研發方面擁有超過25年的經驗。
Related Articles
International
April Richmond Fed Regional Manufacturing Index Rises More than Expected, Services Index Unchanged
The Richmond Fed's monthly manufacturing index rose to a reading of 3 in April from 0 in March, higher than expectations for a smaller increase to 1 in a survey compiled by Bloomberg.Other regional manufacturing data already released have suggested expansion with the exception of the Dallas Fed's measure.Released at the same time, the services revenue index remained unchanged at 9 in April. Other services data have been mixed. The demand index fell to 10 in April from 21 in March.
Research
Research Alert: Abg: Top Line Shortfall Causes Miss, But Margin Improvement Positive
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Asbury Automotive Group (ABG) posted Q1 2026 adjusted EPS of $5.37 vs. $6.82 prior year (-24% Y/Y), short of the $5.62 consensus. Revenue fell 1% to $4.11B ($260M below consensus) and gross margin expanded 20 bps to 17.7% (40 bps above consensus). The revenue shortfall was led by the Finance & Insurance (-4%), New (-2%), and Used Vehicle (-2%) segments, with only Parts & Service (+7%) showing growth. Looking at sales volumes, both new (-5%) and used vehicles (-6%) posted unit declines, but average price realizations were higher (+4% for new and +5% for used). ABG's gross margin improvement was led by the Used Vehicle (+60 bps) segment, partially offset by flat Parts & Service margin and weaker New Vehicle margin (-60 bps). In Q1, ABG repurchased 678K shares for a total of $147M. The quarter marked ABG's first earnings miss in the last six quarters. ABG does not provide formal guidance, but we were at least encouraged by its margin performance. ABG shares are currently trading down 1% in pre-market activity.
$ABG
International